Momenta Phamaceuticals, Inc. (MNTA) Misses Q3 EPS by 24c, Offers Guidance
Tweet Send to a Friend
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q3 EPS of ($0.51), $0.24 worse than the analyst estimate of ($0.27). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
